 | • レポートコード：MRC2-11QY11808 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺気腫治療のグローバル市場について調査・分析したレポートです。種類別（小葉中心性肺気腫、小葉性肺気腫）市場規模、用途別（病院、クリニック、外科センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺気腫治療の競争状況、市場シェア ・世界の肺気腫治療市場：種類別市場規模 2015年-2020年（小葉中心性肺気腫、小葉性肺気腫） ・世界の肺気腫治療市場：種類別市場規模予測 2021年-2026年（小葉中心性肺気腫、小葉性肺気腫） ・世界の肺気腫治療市場：用途別市場規模 2015年-2020年（病院、クリニック、外科センター） ・世界の肺気腫治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック、外科センター） ・北米の肺気腫治療市場分析：米国、カナダ ・ヨーロッパの肺気腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺気腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺気腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺気腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pulmonx、Bioxyne、Intrexon、Icure Pharmaceuticals、Kamada、Emphasys Medical、Pfizer、Olympus、BTG、PneumRx and Uptake Medical、Halozyme Therapeutics、Mariposa Health、Uptake Medical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chronic obstructive pulmonary disease (COPD) is kind of lung disease which happen due to chronic obstruction of lung airflow that interferes with normal breathing and is not fully reversible.
The major driving factor for emphysema treatment in global market is smoking habit of enormous population worldwide.
Market Analysis and Insights: Global Emphysema Treatment Market
The global Emphysema Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Emphysema Treatment Scope and Market Size
Emphysema Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Emphysema Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pulmonx
Bioxyne
Intrexon
Icure Pharmaceuticals
Kamada
Emphasys Medical
Pfizer
Olympus
BTG
PneumRx and Uptake Medical
Halozyme Therapeutics
Mariposa Health
Uptake Medical
Market segment by Type, the product can be split into
Centrilobular emphysema
Panlobular emphysema
Market segment by Application, split into
Hospital
Clinics
Surgical center
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Emphysema Treatment Revenue
1.4 Market by Type
1.4.1 Global Emphysema Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Centrilobular emphysema
1.4.3 Panlobular emphysema
1.5 Market by Application
1.5.1 Global Emphysema Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Surgical center
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Emphysema Treatment Market Perspective (2015-2026)
2.2 Global Emphysema Treatment Growth Trends by Regions
2.2.1 Emphysema Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Emphysema Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Emphysema Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Emphysema Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Emphysema Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Emphysema Treatment Players by Market Size
3.1.1 Global Top Emphysema Treatment Players by Revenue (2015-2020)
3.1.2 Global Emphysema Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Emphysema Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Emphysema Treatment Market Concentration Ratio
3.2.1 Global Emphysema Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Emphysema Treatment Revenue in 2019
3.3 Emphysema Treatment Key Players Head office and Area Served
3.4 Key Players Emphysema Treatment Product Solution and Service
3.5 Date of Enter into Emphysema Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Emphysema Treatment Historic Market Size by Type (2015-2020)
4.2 Global Emphysema Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Emphysema Treatment Market Size by Application (2015-2020)
5.2 Global Emphysema Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Emphysema Treatment Market Size (2015-2020)
6.2 Emphysema Treatment Key Players in North America (2019-2020)
6.3 North America Emphysema Treatment Market Size by Type (2015-2020)
6.4 North America Emphysema Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Emphysema Treatment Market Size (2015-2020)
7.2 Emphysema Treatment Key Players in Europe (2019-2020)
7.3 Europe Emphysema Treatment Market Size by Type (2015-2020)
7.4 Europe Emphysema Treatment Market Size by Application (2015-2020)
8 China
8.1 China Emphysema Treatment Market Size (2015-2020)
8.2 Emphysema Treatment Key Players in China (2019-2020)
8.3 China Emphysema Treatment Market Size by Type (2015-2020)
8.4 China Emphysema Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Emphysema Treatment Market Size (2015-2020)
9.2 Emphysema Treatment Key Players in Japan (2019-2020)
9.3 Japan Emphysema Treatment Market Size by Type (2015-2020)
9.4 Japan Emphysema Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Emphysema Treatment Market Size (2015-2020)
10.2 Emphysema Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Emphysema Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Emphysema Treatment Market Size by Application (2015-2020)
11 India
11.1 India Emphysema Treatment Market Size (2015-2020)
11.2 Emphysema Treatment Key Players in India (2019-2020)
11.3 India Emphysema Treatment Market Size by Type (2015-2020)
11.4 India Emphysema Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Emphysema Treatment Market Size (2015-2020)
12.2 Emphysema Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Emphysema Treatment Market Size by Type (2015-2020)
12.4 Central & South America Emphysema Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pulmonx
13.1.1 Pulmonx Company Details
13.1.2 Pulmonx Business Overview
13.1.3 Pulmonx Emphysema Treatment Introduction
13.1.4 Pulmonx Revenue in Emphysema Treatment Business (2015-2020))
13.1.5 Pulmonx Recent Development
13.2 Bioxyne
13.2.1 Bioxyne Company Details
13.2.2 Bioxyne Business Overview
13.2.3 Bioxyne Emphysema Treatment Introduction
13.2.4 Bioxyne Revenue in Emphysema Treatment Business (2015-2020)
13.2.5 Bioxyne Recent Development
13.3 Intrexon
13.3.1 Intrexon Company Details
13.3.2 Intrexon Business Overview
13.3.3 Intrexon Emphysema Treatment Introduction
13.3.4 Intrexon Revenue in Emphysema Treatment Business (2015-2020)
13.3.5 Intrexon Recent Development
13.4 Icure Pharmaceuticals
13.4.1 Icure Pharmaceuticals Company Details
13.4.2 Icure Pharmaceuticals Business Overview
13.4.3 Icure Pharmaceuticals Emphysema Treatment Introduction
13.4.4 Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2015-2020)
13.4.5 Icure Pharmaceuticals Recent Development
13.5 Kamada
13.5.1 Kamada Company Details
13.5.2 Kamada Business Overview
13.5.3 Kamada Emphysema Treatment Introduction
13.5.4 Kamada Revenue in Emphysema Treatment Business (2015-2020)
13.5.5 Kamada Recent Development
13.6 Emphasys Medical
13.6.1 Emphasys Medical Company Details
13.6.2 Emphasys Medical Business Overview
13.6.3 Emphasys Medical Emphysema Treatment Introduction
13.6.4 Emphasys Medical Revenue in Emphysema Treatment Business (2015-2020)
13.6.5 Emphasys Medical Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Emphysema Treatment Introduction
13.7.4 Pfizer Revenue in Emphysema Treatment Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Olympus
13.8.1 Olympus Company Details
13.8.2 Olympus Business Overview
13.8.3 Olympus Emphysema Treatment Introduction
13.8.4 Olympus Revenue in Emphysema Treatment Business (2015-2020)
13.8.5 Olympus Recent Development
13.9 BTG
13.9.1 BTG Company Details
13.9.2 BTG Business Overview
13.9.3 BTG Emphysema Treatment Introduction
13.9.4 BTG Revenue in Emphysema Treatment Business (2015-2020)
13.9.5 BTG Recent Development
13.10 PneumRx and Uptake Medical
13.10.1 PneumRx and Uptake Medical Company Details
13.10.2 PneumRx and Uptake Medical Business Overview
13.10.3 PneumRx and Uptake Medical Emphysema Treatment Introduction
13.10.4 PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2015-2020)
13.10.5 PneumRx and Uptake Medical Recent Development
13.11 Halozyme Therapeutics
10.11.1 Halozyme Therapeutics Company Details
10.11.2 Halozyme Therapeutics Business Overview
10.11.3 Halozyme Therapeutics Emphysema Treatment Introduction
10.11.4 Halozyme Therapeutics Revenue in Emphysema Treatment Business (2015-2020)
10.11.5 Halozyme Therapeutics Recent Development
13.12 Mariposa Health
10.12.1 Mariposa Health Company Details
10.12.2 Mariposa Health Business Overview
10.12.3 Mariposa Health Emphysema Treatment Introduction
10.12.4 Mariposa Health Revenue in Emphysema Treatment Business (2015-2020)
10.12.5 Mariposa Health Recent Development
13.13 Uptake Medical
10.13.1 Uptake Medical Company Details
10.13.2 Uptake Medical Business Overview
10.13.3 Uptake Medical Emphysema Treatment Introduction
10.13.4 Uptake Medical Revenue in Emphysema Treatment Business (2015-2020)
10.13.5 Uptake Medical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Emphysema Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Emphysema Treatment Revenue
Table 3. Ranking of Global Top Emphysema Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Emphysema Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Centrilobular emphysema
Table 6. Key Players of Panlobular emphysema
Table 7. Global Emphysema Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Emphysema Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Emphysema Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Emphysema Treatment Market Share by Regions (2015-2020)
Table 11. Global Emphysema Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Emphysema Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Emphysema Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Emphysema Treatment Players
Table 18. Global Emphysema Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Emphysema Treatment Market Share by Players (2015-2020)
Table 20. Global Top Emphysema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Emphysema Treatment as of 2019)
Table 21. Global Emphysema Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Emphysema Treatment Product Solution and Service
Table 24. Date of Enter into Emphysema Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Emphysema Treatment Market Size Share by Type (2015-2020)
Table 28. Global Emphysema Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Emphysema Treatment Market Size Share by Application (2015-2020)
Table 30. Global Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Emphysema Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Emphysema Treatment Market Share (2019-2020)
Table 34. North America Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Emphysema Treatment Market Share by Type (2015-2020)
Table 36. North America Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Emphysema Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Emphysema Treatment Market Share (2019-2020)
Table 40. Europe Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Emphysema Treatment Market Share by Type (2015-2020)
Table 42. Europe Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Emphysema Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Emphysema Treatment Market Share (2019-2020)
Table 46. China Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Emphysema Treatment Market Share by Type (2015-2020)
Table 48. China Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Emphysema Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Emphysema Treatment Market Share (2019-2020)
Table 52. Japan Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Emphysema Treatment Market Share by Type (2015-2020)
Table 54. Japan Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Emphysema Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Emphysema Treatment Market Share (2019-2020)
Table 58. Southeast Asia Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Emphysema Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Emphysema Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Emphysema Treatment Market Share (2019-2020)
Table 64. India Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Emphysema Treatment Market Share by Type (2015-2020)
Table 66. India Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Emphysema Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Emphysema Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Emphysema Treatment Market Share (2019-2020)
Table 70. Central & South America Emphysema Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Emphysema Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Emphysema Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Emphysema Treatment Market Share by Application (2015-2020)
Table 74. Pulmonx Company Details
Table 75. Pulmonx Business Overview
Table 76. Pulmonx Product
Table 77. Pulmonx Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 78. Pulmonx Recent Development
Table 79. Bioxyne Company Details
Table 80. Bioxyne Business Overview
Table 81. Bioxyne Product
Table 82. Bioxyne Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 83. Bioxyne Recent Development
Table 84. Intrexon Company Details
Table 85. Intrexon Business Overview
Table 86. Intrexon Product
Table 87. Intrexon Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 88. Intrexon Recent Development
Table 89. Icure Pharmaceuticals Company Details
Table 90. Icure Pharmaceuticals Business Overview
Table 91. Icure Pharmaceuticals Product
Table 92. Icure Pharmaceuticals Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 93. Icure Pharmaceuticals Recent Development
Table 94. Kamada Company Details
Table 95. Kamada Business Overview
Table 96. Kamada Product
Table 97. Kamada Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 98. Kamada Recent Development
Table 99. Emphasys Medical Company Details
Table 100. Emphasys Medical Business Overview
Table 101. Emphasys Medical Product
Table 102. Emphasys Medical Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 103. Emphasys Medical Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Olympus Business Overview
Table 110. Olympus Product
Table 111. Olympus Company Details
Table 112. Olympus Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 113. Olympus Recent Development
Table 114. BTG Company Details
Table 115. BTG Business Overview
Table 116. BTG Product
Table 117. BTG Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 118. BTG Recent Development
Table 119. PneumRx and Uptake Medical Company Details
Table 120. PneumRx and Uptake Medical Business Overview
Table 121. PneumRx and Uptake Medical Product
Table 122. PneumRx and Uptake Medical Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 123. PneumRx and Uptake Medical Recent Development
Table 124. Halozyme Therapeutics Company Details
Table 125. Halozyme Therapeutics Business Overview
Table 126. Halozyme Therapeutics Product
Table 127. Halozyme Therapeutics Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 128. Halozyme Therapeutics Recent Development
Table 129. Mariposa Health Company Details
Table 130. Mariposa Health Business Overview
Table 131. Mariposa Health Product
Table 132. Mariposa Health Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 133. Mariposa Health Recent Development
Table 134. Uptake Medical Company Details
Table 135. Uptake Medical Business Overview
Table 136. Uptake Medical Product
Table 137. Uptake Medical Revenue in Emphysema Treatment Business (2015-2020) (Million US$)
Table 138. Uptake Medical Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Emphysema Treatment Market Share by Type: 2020 VS 2026
Figure 2. Centrilobular emphysema Features
Figure 3. Panlobular emphysema Features
Figure 4. Global Emphysema Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Surgical center Case Studies
Figure 8. Emphysema Treatment Report Years Considered
Figure 9. Global Emphysema Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Emphysema Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Emphysema Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Emphysema Treatment Market Share by Players in 2019
Figure 14. Global Top Emphysema Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Emphysema Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Emphysema Treatment Revenue in 2019
Figure 16. North America Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Emphysema Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…- 非手術性セルライト軽減治療の世界市場（～2026年） Cellulite is a term for the formation of lumps and dimples in the skin. Cellulite can affect both men and women, but it is more common in females, due to the different distributions of fat, muscle, and connective tissue. Cellulite reduction treatments target stubborn lumps and dimpling for a noticea…
- 獣医整形外科治療の世界市場（～2026年） Animals commonly suffer from different orthopedic conditions that result in abnormal movement, instability, lameness, and others. Orthopedic conditions such as hip dysplasia, elbow dysplasia, patella luxation, and others require a surgical procedure for the treatment of the condition. The treatment …
- 医療関連感染（HAI）治療の世界市場（～2026年） Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility. Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million b…
- 腎芽腫治療の世界市場（～2026年） Nephroblastoma is a cancer of the kidneys that typically occurs in children, rarely in adults. Approximately 500 cases are diagnosed in the U.S. annually. The majority (75%) occurs in otherwise normal children; a minority (25%) is associated with other developmental abnormalities. It is highly respo…